SAT-224 Recurrent Co-Driver Mutation in CTNNB1-Mutant Aldosterone-producing Adenomas (APA), Causing Reversible Hypertension in Puberty, Pregnancy or Menopause
Junhua Zhou(Sichuan Agricultural University), Morris J. Brown(St Bartholomew's Hospital), Sheerazed Boulkroun(Inserm), Maria‐Christina Zennaro(Inserm), Louise Metherell(Queen Mary University of London), Suzanne Jordan(Royal London Hospital), Satyamaanasa Polubothu(Great Ormond Street Hospital), Emily Cottrell(Queen Mary University of London), Helen L. Storr(Queen Mary University of London), Claudia Cabrera(Queen Mary University of London), Giulia Argentesi(St Bartholomew's Hospital), Ada Ee Der Teo(University Health System), Antoinette Tuthill(Cork University Hospital), Fiona E. Karet(Howard Hughes Medical Institute), Daniel M. Berney(Queen Mary University of London), Xilin Wu(St Bartholomew's Hospital), Laurence Amar(Unit of Functional and Adaptive Biology), Rajesh V. Thakker(Queen Mary University of London), Fábio L. Fernandes‐Rosa(Inserm), Elena Azizan(University Kebangsaan Malaysia Medical Centre), Veronica A. Kinsler(Great Ormond Street Hospital), William M Drake(St Bartholomew's Hospital), Alison Marker(Cambridge University Hospitals NHS Foundation Trust)
Cited by 0
Related Papers
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Genetic heterogeneity of Barter's syndrome revealed by mutations in the K+ channel, ROMK
|Nature Genetics|1996|824